Is the incidence of candidemia caused by Candida glabrata increasing in Brazil? Five-year surveillance of Candida bloodstream infection in a university reference hospital in southeast Brazil

References

• Pfaller MA, Dikema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20: 133–163.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Dikema DJ. Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility. J Clin Microbiol 2002; 40: 3551–3557.
   PubMed Web of Science ®Google Scholar
• Falagas ME, Roussos N, Vardakas KZ. Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis 2010; 14: e954–966. Epub 2010.
   PubMed Web of Science ®Google Scholar
• Gudlaugsson O, Gillespie S, Lee K, . Attributable mortality of nosocomial candidemia revisited. Clin Infect Dis 2003; 37: 1172–1177.
   PubMed Web of Science ®Google Scholar
• Morgan J, Meltzer MI, Plikaytis BD, . Excess mortality, hospital stay, and cost due to candidemia: a case-control using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol 2005; 26: 540–547.
   PubMed Web of Science ®Google Scholar
• Bassetti M, Taramasso L, Nicco E, . Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS One 2011; 6: e24198. Epub 2011.
   PubMed Web of Science ®Google Scholar
• Das I, Nightngale P, Patel M, Jumaa P. Epidemiology, clinical characteristics, and outcome of candidemia: experience in a tertiary referral center in UK. Int J Infect Dis 2011;15: e759–63.
   PubMed Web of Science ®Google Scholar
• Spilliopoulou A, Vamvakopoulou S, Bartzavali C, . Eleven- year restrospective survey of candidaemia in a university hospital in southwestern Greece. Clin Microbiol Infect 2010; 16: 1378–1381.
   Google Scholar
• Hajjeb RA, Sofair AN, Harrison IH, . Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 2004; 42: 1519–1527.
   Google Scholar
• Pfaller MA, Boyken L, Hollis RJ, . In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance. J Clin Microbiol 2006; 44: 760–763.
   PubMed Web of Science ®Google Scholar
• Tortorano AM, Peman J, Bernhardt H, . and the ECMM working group on candidaemia. Epidemiology of candidemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004; 23: 317–322.
   PubMed Web of Science ®Google Scholar
• Colombo AL, Nucci M, Salomão R, . High rates of non-albicans candidemia in Brazilian tertiary care hospitals. Diagn Microbiol Infect Dis 1999; 34: 281–286.
   PubMed Web of Science ®Google Scholar
• Colombo AL, Nucci M, Park BJ, . for the Brazilian Network Candidemia Study. Epidemiology of Candidemia in Brazil: a national sentinel surveillance of Candidemia in eleven medical centers. J Clin Microbiol 2006, 44: 2816–2823.
   PubMed Web of Science ®Google Scholar
• Motta AL, Almeida GMD, Almeida JN Jr, Burattini MN, Rossi F. Candidemia epidemiology and susceptibility profile in the largest Brazilian teaching hospital complex. Braz J Infect Dis 2010; 15: 441–448.
   Google Scholar
• Levin AS, Costa SF, Mussi NS, . Candida parapsilosis fungemia associated with implantable and semi-implantable central venous catheter and the hands of healthcare workers. Diagn Microbiol Infect Dis 1998; 30: 243–249.
   PubMed Web of Science ®Google Scholar
• Kuhn DM, Mukherjee PK, Clark TA, . Candida parapsilosis characterization in an outbreak setting. Emerg Infect Dis 2004; 10: 1074–1081.
   PubMed Web of Science ®Google Scholar
• Bassetti M, Ansaldi F, Nicolini L, . Incidence of candidaemia and relationship with fluconazole use in an intensive care unit. J Antimicrob Chemother 2009; 64: 625–629.
   PubMed Web of Science ®Google Scholar
• Lass-Flörl C. The changing face of epidemiology of invasive fungal disease in Europe. Mycoses 2009; 52: 197–205
   PubMed Web of Science ®Google Scholar
• Girão E, Levin AS, Basso M, . Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in intensive care units at a Brazilian University hospital. Med Mycol 2008; 46: 581–588.
   PubMed Web of Science ®Google Scholar
• Mermel LA, Allon M, Bouza E, . Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49: 1–45.
   PubMed Web of Science ®Google Scholar
• WHO Collaborating Centre for Drug Statistics Methodology [database on the internet]. Oslo (Norway): Norwegian Institute of Public Health. c2004-[cited 2011 Apr 8]. Available from: http://www.whocc.no/ddd.
   Google Scholar
• Dean AG, Sullivan KM, Soe MM. OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version 2.3.1. www.OpenEpi.com, updated 2011/23/06.
   Google Scholar
• REDE Interagencial de Informação para a Saúde (eds) [Interagency Network for Health Information (eds)]. Indicadores Básicos Para A Saúde No Brasil: Conceitos E Aplicações [Basic Indicators For Health In Brazil: Concepts And Applications]. 1st edn. Brasília: Pan-American Health Organization PAHO/WHO, 2002. [in Portuguese].
   Google Scholar
• Hinrichesen SL, Falcão E, Vilella TAS, . Candidemia em hospital terciário do nordeste do Brasil. [Candidemia in a tertiary hospital in northeastern Brazil]. Rev Soc Bras Med Trop 2008; 41: 394–398 [in Portuguese].
   Google Scholar
• Colombo AL, Thompson L, Graybill JR. The north and south candidemia: issues from Latin America. Drugs Today 2008; 44 (Suppl. A): 1–34.
   Google Scholar
• Nucci M, Queiroz-Telles F, Tobón AM, Restrepo A, Colombo AL. Epidemiology of opportunistic fungal infections in Latin America. Clin Infect Dis 2010; 51: 561–570.
   PubMed Web of Science ®Google Scholar
• Chen SCA, Marriott D, Playford EG, . and the Australian candidaemia study. Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.Clin Microbiol Infect 2009; 15: 662–669.
   PubMed Web of Science ®Google Scholar
• Ortega M, Marco F, Soriano A, . Candida species bloodstream infections: epidemiology and outcome in a single institution from 1991 to 2008. J Hosp Infect 2011; 77: 157–161.
   PubMed Web of Science ®Google Scholar
• Nucci M, Colombo AL. Candidemia due to Candida tropicalis: clinical, epidemiologic, and microbiologic characteristics of 188 episodes occurring in tertiary care hospitals. Diagn Microbiol Infect Dis 2007; 58: 77–82.
   PubMed Web of Science ®Google Scholar
• White M. The contribution of fluconazole to the changing epidemiology of invasive Candida infections. Clin Infect Dis 1997; 24: 1129–1130.
   PubMed Web of Science ®Google Scholar
• Pasqualotto AC, Zimerman RA, Alves SH, . Take control over your fluconazole prescriptions: the growing importance of Candida glabrata as an agent of candidemia in Brazil. Infect Control Hosp Epidemiol 2008; 29: 898–899.
   PubMed Web of Science ®Google Scholar
• Malani A, Hmoud J, Chiu L, . Candida glabrata fungemia: experience in a tertiary care center. Clin Infect Dis 2005; 41: 975–981.
   PubMed Web of Science ®Google Scholar
• Lin MY, Carmeli Y, Zumsteg J, . Prior antimicrobial therapy and risk of hospital-acquired Candida glabrata and Candida krusei fungemia: a case-control study. Antimicrob Agents Chemother 2005; 49: 4555–4560.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Messer SA, Moet GJ, Jones RN, Castanheira M. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008–2009). Int J Antimicrob Agents 2011; 38: 65–69. Epub 2011 Apr 22.
   PubMed Web of Science ®Google Scholar
• Kett DH, Azoulay E, Echeverria PM,Vincent JL; Extended Prevalence of Infection in ICU Study (EPIC II) Group of Investigators. Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med 2011; 39: 665–670.
   PubMed Web of Science ®Google Scholar
• Leenders NH, Oosterheert JJ, Ekkelenkamp MB, . Candidemic complications in patients with intravascular catheters colonized with Candida species: an indication for preemptive antifungal therapy? Int J Infect Dis 2011; 15: e453–458.
   Web of Science ®Google Scholar
• Yapar N, Pullukcu H, Avkan-Oguz V, . Evaluation of species distribution and risk factors of candidemia: a multicenter case-control study. Med Mycol 2011; 49: 26–31.
   PubMed Web of Science ®Google Scholar
• Abi-Said D, Anaissie E, Uzun O, . The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997; 24: 1122–1128.
   PubMed Web of Science ®Google Scholar
• Blumberg HM, Jarvis WR, Soucie JM, . Risk factors for Candida bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. Clin Infect Dis 2001; 33: 177–186.
   PubMed Web of Science ®Google Scholar
• Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunossuppressed patients. Lancet 2003; 3: 685–702.
   Web of Science ®Google Scholar